Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease
- PMID: 8017169
- DOI: 10.1007/BF00313602
Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease
Abstract
Immunohistochemistry using both a newly developed polyclonal, and a commercially available monoclonal, anti-insulin receptor antibody was done on the midbrain from cases of idiopathic Parkinson's disease (PD), Alzheimer's disease, amyotrophic lateral sclerosis, vascular parkinsonism and non-neurological controls. Both antibodies gave identical patterns of neuronal staining. The neurons of the oculomotor nucleus were immunopositive in all the brains. However, the neurons in the pars compacta of the substantia nigra, paranigral nucleus, parabrachial pigmental nucleus, tegmental pedunculopontine nucleus, supratrocheal nucleus, cuneiform nucleus, subcuneiform nucleus and lemniscus medialis, which were positive in other diseases and in non-neurological controls, were not stained by these antibodies in PD brains. These results suggest that, in PD, a dysfunction of the insulin/insulin receptor system may precede death of the dopaminergic neurons.
Similar articles
-
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.Brain. 1999 Aug;122 ( Pt 8):1437-48. doi: 10.1093/brain/122.8.1437. Brain. 1999. PMID: 10430830
-
An altered histaminergic innervation of the substantia nigra in Parkinson's disease.Exp Neurol. 2000 May;163(1):20-30. doi: 10.1006/exnr.2000.7362. Exp Neurol. 2000. PMID: 10785440
-
Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.J Comp Neurol. 1993 Mar 15;329(3):328-36. doi: 10.1002/cne.903290304. J Comp Neurol. 1993. PMID: 8459049
-
Detrimental deletions: mitochondria, aging and Parkinson's disease.Bioessays. 2006 Oct;28(10):963-7. doi: 10.1002/bies.20471. Bioessays. 2006. PMID: 16998822 Review.
-
Neuronal vulnerability in Parkinson's disease.Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S52-4. doi: 10.1016/S1353-8020(11)70018-9. Parkinsonism Relat Disord. 2012. PMID: 22166454 Review.
Cited by
-
The Relevance of Insulin Action in the Dopaminergic System.Front Neurosci. 2019 Aug 16;13:868. doi: 10.3389/fnins.2019.00868. eCollection 2019. Front Neurosci. 2019. PMID: 31474827 Free PMC article. Review.
-
Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches.Brain Sci. 2018 Sep 15;8(9):177. doi: 10.3390/brainsci8090177. Brain Sci. 2018. PMID: 30223579 Free PMC article. Review.
-
Commonality between diabetes and Alzheimer's disease and a new strategy for the therapy.Clin Med Pathol. 2008;1:83-91. doi: 10.4137/cpath.s667. Epub 2008 Jul 28. Clin Med Pathol. 2008. PMID: 21876656 Free PMC article. No abstract available.
-
Significance of Brain Glucose Hypometabolism, Altered Insulin Signal Transduction, and Insulin Resistance in Several Neurological Diseases.Front Endocrinol (Lausanne). 2022 May 9;13:873301. doi: 10.3389/fendo.2022.873301. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35615716 Free PMC article. Review.
-
Elucidating the Relationship Between Diabetes Mellitus and Parkinson's Disease Using 18F-FP-(+)-DTBZ, a Positron-Emission Tomography Probe for Vesicular Monoamine Transporter 2.Front Neurosci. 2020 Jul 14;14:682. doi: 10.3389/fnins.2020.00682. eCollection 2020. Front Neurosci. 2020. PMID: 32760240 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous